FDA pulls approval of COVID-19 antibody treatment due to inefficacy against variants
Pharmafile
JANUARY 27, 2023
The antibody treatment was previously used as an additional layer of protection against the virus for those with compromised immune systems, such as those undergoing chemotherapy, or organ-transplant patients. read more
Let's personalize your content